Living kidney donor evaluation for all candidates with normal estimated GFR for age.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
06 2021
Historique:
revised: 01 03 2021
received: 10 11 2020
accepted: 21 03 2021
pubmed: 29 3 2021
medline: 3 7 2021
entrez: 28 3 2021
Statut: ppublish

Résumé

Multiple days assessments are frequent for the evaluation of candidates to living kidney donation, combined with an early GFR estimation (eGFR). Living kidney donation is questionable when eGFR is <90 ml/min/1.73 m

Identifiants

pubmed: 33774875
doi: 10.1111/tri.13870
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1133

Informations de copyright

© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Moore DR, Feurer ID, Zaydfudim V, et al. Evaluation of living kidney donors: variables that affect donation. Prog Transplant Aliso Viejo Calif 2012; 22: 385.
Lapasia JB, Kong S, Busque S, Scandling JD, Chertow GM, Tan JC. Living donor evaluation and exclusion: the stanford experience. Clin Transplant 2011; 25: 697.
Habbous S, Woo J, Lam NN, et al. The efficiency of evaluating candidates for living kidney donation: a scoping review. Transplant Direct 2018; 4: e394.
Knoll GA, Fortin M-C, Gill J, et al. Measuring quality in living donation and kidney transplantation: moving beyond survival metrics. Kidney Int 2020; 98: 860.
Habbous S, McArthur E, Sarma S, et al. Potential implications of a more timely living kidney donor evaluation. Am J Transplant 2018; 18: 2719.
Lentine KL, Levey AS, Segev DL. Integrated risk assessment versus age-specific GFR thresholds for living donor candidate evaluation. Transplantation 2020; 104: 2464.
Gaillard F, Courbebaisse M, Kamar N, et al. Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. Kidney Int 2019; 95: 896.
Lentine KL, Kasiske BL, Levey AS, et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 2017; 101(8 Suppl 1): S7.
Garg N, Lentine KL, Inker LA, et al. The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant 2020; 20: 3379.
Gaillard F, Jacquemont L, Roberts V, et al. Temporal trends in living kidney donation in France between 2007 and 2017. Nephrol Dial Transplant 2021; 36: 730.
Al Ammary F, Bowring MG, Massie AB, et al. The changing landscape of live kidney donation in the United States from 2005 to 2017. Am J Transplant 2019; 19: 2614.
Steiner RW. The risks of living kidney donation. N Engl J Med 2016; 374: 479.
Steiner RW. Amending a historic paradigm for selecting living kidney donors. Am J Transplant 2019; 19: 2405.
Steiner RW. “You can’t get there from here”: critical obstacles to current estimates of the ESRD risks of young living kidney donors. Am J Transplant 2019; 19: 32.
Massie AB, Holscher CM, Henderson ML, et al. Association of early postdonation renal function with subsequent risk of end-stage renal disease in living kidney donors. JAMA Surg 2020; 155: e195472.
Thuong M. Prélèvement et greffe rénale à partir de donneur vivant. Recommandations formalisées d’experts-texte court. Néphrol Thér 2010; 6: 138.
Délibération N° 2018-155 Du 3 Mai 2018 Portant Homologation de La Méthodologie de Référence Relative Aux Traitements de Données à Caractère Personnel Mis En Œuvre Dans Le Cadre Des Recherches n’impliquant Pas La Personne Humaine, Des Études et Évaluations Dans Le Domaine de La Santé (MR-004). Accessed April 14, 2019. https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000037187498&categorieLien=id.
Agence de la biomédecine - Le rapport annuel médical et scientifique 2017. Accessed May 19, 2019. https://www.agence-biomedecine.fr/annexes/bilan2017/donnees/organes/06-rein/synthese.htm.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.
Gaillard F, Fournier C, Legendre C. Lifetime ESKD risk stratification for living kidney donor studies. Am J Transplant 2019; 19: 2658.
Pottel H, Delanaye P, Weekers L, et al. Age-dependent reference intervals for estimated and measured glomerular filtration rate. Clin Kidney J 2017; 10: 545.
Ibrahim HN, Foley R, Tan LiPing, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459.
Wickham H, Chang W, Henry L, et al. Ggplot2: create elegant data visualisations using the grammar of graphics, 2019. Accessed June 1, 2019. https://CRAN.R-project.org/package=ggplot2.
Gaillard F, Courbebaisse M, Kamar N, et al. The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney Int 2018; 94: 616.
Steiner RW. “Normal for now” or “at future risk”: a double standard for selecting young and older living kidney donors. Am J Transplant 2010; 10: 737.
Wainright JL, Robinson AM, Wilk AR, Klassen DK, Cherikh WS, Stewart DE. Risk of ESRD in prior living kidney donors. Am J Transplant 2018; 18: 1129.
Lam NN, Lloyd A, Lentine KL, et al. Changes in kidney function follow living donor nephrectomy. Kidney Int 2020; 98: 176.
Kasiske BL, Anderson-Haag TL, Duprez DA, et al. A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years. Kidney Int 2020; 98: 168.
Steiner RW. Increased single-nephron GFR in normal adults: too much of a good thing … or maybe not? Am J Kidney Dis 2018; 71: 312.
Graham JM, Courtney AE. The adoption of a one-day donor assessment model in a living kidney donor transplant program: a quality improvement project. Am J Kidney Dis 2018; 71: 209.

Auteurs

François Gaillard (F)

Department of Nephrology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Centre de recherche sur l'inflammation, INSERM UMR1149, CNRS EL8252, Laboratoire d'Excellence Inflamex, Université de Paris, Paris, France.

Lola Jacquemont (L)

Nephrology and Renal Transplantation Department, CHU Nantes, Nantes, France.

Hélène Lazareth (H)

Nephrology Department, Hopital Européen Georges Pompidou, Paris, France.

Laetitia Albano (L)

Nephrology and Renal Transplantation Department, Pasteur Hospital, Nice, France.

Benoit Barrou (B)

Urology Department, Pitié-Salpêtrière, Paris, France.

Nicolas Bouvier (N)

Nephrology, Dialysis, Transplantation Department, CHU Cote de Nacre, Caen University, Caen, France.

Mathias Buchler (M)

Service de Néphrologie et Immunologie Clinique, CHU Tours, Université de Tours, Tours, France.

Dimitri Titeca-Beauport (D)

Nephrology, Dialysis and Transplantation Department, University Hospital, Amiens, France.

Lionel Couzi (L)

Nephrology, Transplantation and Dialysis, CHU Bordeaux, CNRS UMR 5164, Bordeaux University, Bordeaux, France.

Michel Delahousse (M)

Nephrology, Dialysis and Renal Transplantation Department, Foch Hospital, Suresnes, France.

Didier Ducloux (D)

Nephrology, Dialysis and Transplantation Department, CHU Besançon, Besançon, France.

Isabelle Etienne (I)

Nephrology Department, CHU, Rouen, France.

Luc Frimat (L)

Nephrology, Dialysis and Transplantation Department, CHU, Nancy, France.

Cyril Garrouste (C)

Nephrology, Dialysis and Transplantation Department, CHU, Clermont Ferrand, France.

Denis Glotz (D)

Department of Nephrology and Renal Transplantation, Hopital Saint Louis, Paris, France.

Philippe Grimbert (P)

Nephrology and Transplantation Department, UPEC University, Créteil, France.

Marc Hazzan (M)

Nephrology Department, University Hospital, Lille, France.

Alexandre Hertig (A)

Nephrology and Transplantation, Hopital Pitié Salpétrière, Paris, France.

Maryvonne Hourmant (M)

Nephrology and Renal Transplantation Department, CHU Nantes, Nantes, France.

Nassim Kamar (N)

Department of Nephrology, Dialysis and Organ Transplantation, CHU Rangueil, INSERM U1043, IFR-BMT, University Paul Sabatier, Toulouse, France.

Yann Le Meur (Y)

Department of Nephrology and Renal Transplantation, CHU Brest, Brest, France.

Moglie Le Quintrec (M)

Nephrology, Transplantation and Dialysis Department, CHU Lapeyronie, and IRMB, INSERM U1183, Montpellier, France.

Christophe Legendre (C)

Nephrology and Renal Transplantation Department, Hopital Necker, Paris, France.

Valérie Moal (V)

Nephrology and Renal Transplantation, APHM, Marseille, France.

Bruno Moulin (B)

Nephrology and Transplantation Department, University Hospital, Strasbourg, France.

Christiane Mousson (C)

Nephrology Department, University Hospital, Dijon, France.

Claire Pouteil-Noble (C)

Renal Transplantation Department, Hospices Civils de Lyon, Claude Bernard University, Lyon, France.

Philippe Rieu (P)

Nephrology and Renal Transplantation Department, University Hospital, Reims, France.

Nacera Ouali (N)

Nephrology and Renal Transplantation, Hopital Tenon, Paris, France.

Lionel Rostaing (L)

Nephrology, Hemodialysis, Apheresis and Transplantation Department, University Hospital, Grenoble, France.

Antoine Thierry (A)

Nephrology Department, University Hospital and Poitiers University, INSERM U1082, Poitiers, France.

Fatouma Toure (F)

Nephrology, Dialysis and Renal Transplantation Department, CHU, Limoges, France.

Jonathan Chemouny (J)

Nephrology, Dialysis and Transplantation Department, University Hospital, Rennes, France.

Pierre Delanaye (P)

Department of Nephrology-Dialysis-Transplantation, University of Liège (ULg CHU), Liège, Belgium.
Department of Nephrology-Dialysis-Apheresis, Hopital Universitaire Caremeau, Nimes, France.

Marie Courbebaisse (M)

Department of Physiology, European Georges Pompidou Hospital, APHP, INSERM U1151, Paris University, Paris, France.

Christophe Mariat (C)

Nephrology, Dialysis and Renal Transplantation Department, Hôpital Nord, CHU de Saint-Etienne, Jean Monnet University, COMUE Université de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH